During hepatoma progression, this biological process could be reversed by aberrantly low HBP1 expression, which promotes AFP effect on PTEN, MMP9 and caspase-3, thus induces proliferation and migration, and inhibits apoptosis in hepatoma cells. Here, MMP9 is linked to hepatocellular carcinoma.